Insider trades

Barbara Klencke, Director of TScan Therapeutics TCRX, has filed 4 purchases and 0 sales on the open market. The latest trade was on 05/20.

Barbara Klencke

Director
First filing
23/01/24
Trades
22 trades
Buys / sales
4 / 0
12-month net buying
No record
Last trade
05/20

Trading activity

Transactions

Trade type
Open-market buy24/09/2324/09/245,000 sh$5.29$26,450+12.5%
TCRX
Open-market buy24/08/23–24/08/2624/08/2710,000 sh2 trades$5.61avg.$56,100+33.3%
Open-market buy23/12/1423/12/185,000 sh$5.08$25,400+20.0%